GARRISON POINT ADVISORS, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1767107 Walnut Creek, CA

Position in GILD

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$251,921

-$25,704 QoQ

Shares Held

1,994

+0.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#1,781

of 2,266 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GARRISON POINT ADVISORS, LLC holds $11,648,529 across 8 Drug Manufacturers - General names. GILD ranks #8 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	16,613	$4,219,203
2	AMGN	Amgen Inc	5,460	$1,977,175
3	NVO	Novo Nordisk A S	33,268	$1,594,867
4	MRK	Merck & Co., Inc.	12,116	$1,556,906
5	BMY	Bristol Myers Squibb Co	15,198	$875,708
6	ABBV	AbbVie Inc.	3,016	$758,946
7	LLY	ELI LILLY & Co	345	$413,803
8	GILD	Gilead Sciences, Inc. This page	1,994	$251,921

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$251,921	1,994	+0.1%	Shares	Sole	2026-07-31
2026-03-31	$277,625	1,992	+0.1%	Shares	Sole	2026-05-13
2025-12-31	$244,252	1,990	-46.0%	Shares	Sole	2026-02-13
2025-09-30	$409,368	3,688	+0.1%	Shares	Sole	2025-10-22
2025-06-30	$408,666	3,686	-2.6%	Shares	Sole	2025-08-06
2025-03-31	$423,997	3,784	+0.1%	Shares	Sole	2025-05-13
2024-12-31	$349,343	3,782	+0.1%	Shares	Sole	2025-02-13
2024-09-30	$316,915	3,780	-2.8%	Shares	Sole	2024-10-23
2024-06-30	$266,755	3,888	+4.1%	Shares	Sole	2024-08-07
2024-03-31	$273,515	3,734	+0.1%	Shares	Sole	2024-05-09
2023-12-31	$302,167	3,730	+0.1%	Shares	Sole	2024-02-08
2023-09-30	$279,301	3,727	+0.1%	Shares	Sole	2023-10-18
2023-06-30	$286,931	3,723	+0.1%	Shares	Sole	2023-07-25
2023-03-31	$308,648	3,720	—	Shares	Sole	2023-05-05
No filing history on record for this holder in this stock.